Litopenaeus

Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatments

Retrieved on: 
Lundi, mai 6, 2024
Research, Genetics, Clinical Trials, Other Health, Biotechnology, Health, Agriculture, Natural Resources, Science, Other Science, Mortality, African swine fever virus, Viral disease, CRISPR, Gene targeting, Hope, White, Chicken, Synthetic control method, Blood, ASF, Classical swine fever, Cas, ELISA, Animal, Survival, Litopenaeus, Infection, Doctor of Philosophy, Disease, ASFV, Real-time, Food security, Viral load, Food, Seek, H5N1, Genome, Candidate, Viral, Pharmacy, Injection, WSSV, Medication, Vaccine

Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced today the successful completion of a therapeutic trial using innovative CRISPR-based technologies to target the African Swine Fever Virus (ASFV) in pigs.

Key Points: 
  • Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced today the successful completion of a therapeutic trial using innovative CRISPR-based technologies to target the African Swine Fever Virus (ASFV) in pigs.
  • The trial, which aimed to replicate and expand an earlier trial, demonstrated pigs infected with ASFV and treated with Seek Labs’ CRISPR-based systems survived longer than untreated infected pigs.
  • With no available treatments for African Swine Fever, this is a breakthrough discovery.
  • Seek Labs’ work represents a beacon of hope for the swine industry and underscores the transformative potential of CRISPR-based technology in global healthcare.

Colors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology

Retrieved on: 
Mardi, octobre 31, 2023
Knowledge, Gene editing, Litopenaeus, US, Disease resistance, Ben-Gurion University of the Negev, Economics, Seafood, CRISPR, RNA, BGU, Computational biology, Research, TASE, IIA, Generator, Israel Innovation Authority, CPO, Macrobrachium, Compound annual growth rate, Aquaculture, Appetite, Antibiotics

HAZEVA and REHOVOT, Israel, Oct. 31, 2023 /PRNewswire/ -- Colors Farm Ltd, a cutting-edge company in sustainable aquaculture and biotech and Evogene Ltd. ("Evogene") (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product discovery and development, today announced a collaboration with Ben-Gurion University (BGU), a renowned Israeli academic research institution, to develop gene editing technology for crustaceans. This synergistic collaboration will focus on crustaceans — specifically targeting giant freshwater prawn (Macrobrachium rosenbergii), white leg shrimp (Litopenaeus vannamei) and red swamp crayfish (Procambarus clarkii), to enhance key traits such as growth rate, disease resistance, and environmental adaptation. The initiative has received a competitive grant from the Israel Innovation Authority (IIA), cementing its role as a pioneering endeavor in the realm of precision agriculture.

Key Points: 
  • Gene editing is a powerful tool that can enhance the economics and sustainability of crustacean production.
  • Ran Epstein, CEO of Colors Farm, emphasized the potential impact of gene editing on crustacean production: "This collaboration represents a major step forward for aquaculture.
  • Gene editing has the power to revolutionize crustacean production, and we are excited to work with Evogene and BGU to turn this potential into reality."
  • "We are pleased to collaborate with Colors Farm and BGU on this significant endeavor" said Nir Arbel, CPO of Evogene: "Through precise modifications of crustacean genomes, gene editing can enhance desired traits and minimize environmental impact.

$9.03 Bn Asia Pacific Aqua Feed and Aqua Feed Additives Markets, 2019-2024 - ResearchAndMarkets.com

Retrieved on: 
Mardi, juillet 2, 2019
Food, Beverage, Consumer, Retail, Pets, Penaeidae, Edible crustaceans, Litopenaeus, Whiteleg shrimp, Compound annual growth rate, BASF, Companies, Economy

The "Asia Pacific Aqua Feed and Aqua Feed Additives Market - Growth, Trends and Forecast (2019-2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Asia Pacific Aqua Feed and Aqua Feed Additives Market - Growth, Trends and Forecast (2019-2024)" report has been added to ResearchAndMarkets.com's offering.
  • By species, litopenaeus vannamei accounted for the largest share in the Indian aquafeed market, accounting for 54% of share in 2018.
  • It is also expected to be the fastest growing, while registering a CAGR of 6.0% during the forecast period.
  • Moreover, BASF South East Asia Pte Ltd, Adisseo Asia Pacific Lte ltd are major players in the Asia-Pacific aquafeed additives market.